Elevated miRNA-21-5p levels have been reported in the serum of SSc patients [20], and TGF-β stimulation in skin fibroblasts increases miRNA-21-5p, which negatively regulates SMAD7, exhibiting profibrogenic effects [21]. The gene discussed is SMAD7; the disease is systemic sclerosis.